FASLG and pancreatic neoplasm: The results indicate that reduced DcR3 could greatly enhance the proapoptotic effect of TRAIL in these 2 pancreatic cancer cell lines (as compared to FasL and LIGHT), whereas DcR3 is utilized by these cells to counteract the proapoptotic effect of TRAIL.